Latest filing published 21 Jun 2024 for Hansa Biopharma AB, €35k.
Filing timeline
BuySaleInsider track record
Closed purchases
Based on 2 purchases whose 90-day window has closed (published at least 91 days ago), the same population our ranking model reads.
Purchases by company
Since each purchase
- +204.4%Entry SEK 79.05 · Close at T+365 SEK 240.60
- -33.7%Entry SEK 172.90 · Close at T+365 SEK 114.60
Entry is the close on the day after publication, the first price a reader could act on. Prices in the listing currency. Past moves are not a forecast.
Soren Tulstrup: trading record in brief
Soren Tulstrup appears in our data through filings on Hansa Biopharma AB shares, published by Finansinspektionen. The record holds 10 filings, for trades running from 3 May 2019 to 17 June 2024.
In open-market terms, that means 7 purchases worth €215k on one side and 2 sales worth €53k on the other. The totals exclude 1 filing filed without an amount. Open-market purchases are the filings investors watch most closely, because the insider pays for the shares out of pocket. The rest of the record consists of 1 share grant. In 2024 alone, the filings show 1 purchase and 1 sale.
In size, the median ticket on the buying side is €28k. Clusters matter here: 2 out of 3 purchases overlapped with buying by a colleague within 30 days. Purchases made close together by different insiders form what is called a cluster.
On 21 June 2024 came the latest disclosure, an open-market sale for €35k in Hansa Biopharma AB. The most recent open-market purchase was published on 21 June 2024, 870 days ago. Typically, a trade is published a median of 3 days after it takes place. Under the Market Abuse Regulation, managers have three business days to notify their trades. These figures are compiled from regulatory filings published by Finansinspektionen. They describe what insiders did and are not a recommendation.
Companies and markets linked to Soren Tulstrup
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 9,199 shares@ SEK 42.27AktieISIN SE0002148817FI:csv-58e296b66f769693872b
- 35,200 shares0AktieISIN SE0002148817FI:csv-ded20c6f18663bdfc2bbCanonical exit: 15 Sept 2024 (T+90)
- 5,000 shares@ SEK 23.0284AktieISIN SE0002148817FI:csv-e88c591f10ef507f3151Canonical exit: 6 Mar 2024 (T+90)
- 3,925 shares@ SEK 49.9925.8% of flowAktieISIN SE0002148817FI:csv-fae9baac40fc13f592c4
- 3,925 shares@ SEK 49.9925.8% of flowAktieISIN SE0002148817FI:csv-730504b2b811127cc03bCanonical exit: 15 Sept 2022 (T+90)
- 15,466 shares0AktieISIN SE0002148817FI:csv-344426df0c23dcf26e4d
- 2,000 shares@ SEK 111.1857AktieISIN SE0002148817FI:csv-9b46e501f189d3811213Canonical exit: 14 Oct 2021 (T+90)
- 3,000 shares@ SEK 150.2758AktieISIN SE0002148817FI:csv-9b9769064ba26d032c62Canonical exit: 5 Aug 2021 (T+90)
- 5,000 shares@ SEK 71.551100.0% of flowAktieISIN SE0002148817FI:csv-987b286f05126686fc0cCanonical exit: 15 Mar 2020 (T+90)
- 5,000 shares@ SEK 185.00100.0% of flowAktieISIN SE0002148817FI:csv-0575c45f847b3c7509b9Canonical exit: 1 Aug 2019 (T+90)
10 of 10 declarations